Rebekka Wegmann

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanoma.

Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanoma.

Journal: Nature medicine
Published: August 01, 2025

A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy.

A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy.

Journal: Nature communications
Published: March 09, 2025

Feasibility of multiomics tumor profiling for guiding treatment of melanoma.

Feasibility of multiomics tumor profiling for guiding treatment of melanoma.

Journal: Nature medicine
Published: July 09, 2024

Molecular and functional landscape of malignant serous effusions for precision oncology.

Molecular and functional landscape of malignant serous effusions for precision oncology.

Journal: Nature communications
Published: June 14, 2024

Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemia.

Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemia.

Journal: Nature communications
Published: March 08, 2024

High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity.

High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity.

Journal: Nature medicine
Published: December 06, 2023

ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma.

ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma.

Journal: Cancer research
Published: June 03, 2022

Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma.

Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma.

Journal: Nature cancer
Published: April 27, 2022

A functional analysis of 180 cancer cell lines reveals conserved intrinsic metabolic programs.

A functional analysis of 180 cancer cell lines reveals conserved intrinsic metabolic programs.

Journal: Molecular systems biology
Published: March 17, 2022

The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support.

The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support.

Journal: Cancer cell
Published: January 22, 2021

CellSIUS provides sensitive and specific detection of rare cell populations from complex single-cell RNA-seq data.

CellSIUS provides sensitive and specific detection of rare cell populations from complex single-cell RNA-seq data.

Journal: Genome biology
Published: May 07, 2019

Mapping human microbiome drug metabolism by gut bacteria and their genes.

Mapping human microbiome drug metabolism by gut bacteria and their genes.

Journal: Nature
Published: December 31, 2018
Showing 1-12 of 13

Last Updated: 09/26/2026